{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:56:10Z","timestamp":1792007770967,"version":"4.4.0"},"reference-count":144,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Cell\u2013cell signaling through a network of cytokine receptors is pivotal for normal immune development and function, with disruptions of these signaling pathways being implicated in a variety of immune cell diseases. Signaling via the interleukin-7 receptor (IL-7R) facilitates the development and homeostasis of various T-cell, B-cell and other immune-cell populations. This is reflected in the raft of mutants and variants of IL-7R components and downstream signaling molecules that have been identified in the context of immunodeficiencies, autoimmune disorders and lymphoid malignancies, but also through the use of pathway modulators as therapeutics. This review provides an overview of IL-7R biology, the role of mutations and variants affecting IL-7R signaling pathway components in the etiology of immune cell diseases and the specific therapies related to this pathway.<\/jats:p>","DOI":"10.3390\/biom16020219","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:00:47Z","timestamp":1770033647000},"page":"219","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Interleukin-7 Receptor Signaling Pathway and Its Perturbation in Immunodeficiency, Autoimmune Disease and Lymphoid Malignancy"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7945-7975","authenticated-orcid":false,"given":"Alister C.","family":"Ward","sequence":"first","affiliation":[{"name":"School of Medicine, Deakin University, Geelong, VIC 3216, Australia"},{"name":"Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC 3216, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The gammac family of cytokines: Basic biology to therapeutic ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Liongue, C., O\u2019Sullivan, L.A., Trengove, M.C., and Ward, A.C. (2012). Evolution of JAK-STAT pathway components: Mechanisms and role in immune system development. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032777"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","article-title":"Flip the coin: IL-7 and IL-7R in health and disease","volume":"20","author":"Barata","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"156049","DOI":"10.1016\/j.cyto.2022.156049","article-title":"IL-7: Comprehensive review","volume":"160","author":"Winer","year":"2022","journal-title":"Cytokine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4110\/in.2011.11.1.1","article-title":"Seeing is believing: Illuminating the source of in vivo interleukin-7","volume":"11","author":"Kim","year":"2011","journal-title":"Immune Netw."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.1116582109","article-title":"Structural reorganization of the interleukin-7 signaling complex","volume":"109","author":"McElroy","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.str.2008.10.019","article-title":"Structural and biophysical studies of the human IL-7\/IL-7Ralpha complex","volume":"17","author":"McElroy","year":"2009","journal-title":"Structure"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","article-title":"The role of shared receptor motifs and common STAT proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15","volume":"2","author":"Lin","year":"1995","journal-title":"Immunity"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1128\/MCB.24.14.6501-6513.2004","article-title":"Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members","volume":"24","author":"Jiang","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2567.2009.03244.x","article-title":"Interleukin-7 promotes the survival of human CD4+ effector\/memory T cells by up-regulating Bcl-2 proteins and activating the JAK\/STAT signalling pathway","volume":"130","author":"Chetoui","year":"2010","journal-title":"Immunology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1084\/jem.20051520","article-title":"IL-7 promotes T cell proliferation through destabilization of p27Kip1","volume":"203","author":"Li","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(00)80052-7","article-title":"Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors","volume":"10","author":"Pallard","year":"1999","journal-title":"Immunity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ni.1827","article-title":"Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development","volume":"11","author":"Malin","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_15","first-page":"47","article-title":"Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia","volume":"360","author":"Alcain","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1038\/s41375-021-01291-5","article-title":"MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance","volume":"35","author":"Cordo","year":"2021","journal-title":"Leukemia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lodewijckx, I., and Cools, J. (2021). Deregulation of the interleukin-7 signaling pathway in lymphoid malignancies. Pharmaceuticals, 14.","DOI":"10.3390\/ph14050443"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2009-10-246876","article-title":"IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells","volume":"115","author":"Henriques","year":"2010","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2007-06-096297","article-title":"IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival","volume":"111","author":"Wofford","year":"2008","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4049\/jimmunol.1900456","article-title":"IL-7R-dependent phosphatidylinositol 3-kinase competes with the STAT5 signal to modulate T cell development and homeostasis","volume":"204","author":"Cui","year":"2020","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41423-020-0409-8","article-title":"Identification of alternatively spliced Il7r transcripts in mouse T cells that encode soluble IL-7Ralpha","volume":"17","author":"Won","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Markovic, I., and Savvides, S.N. (2020). Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01557"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"a028449","DOI":"10.1101\/cshperspect.a028449","article-title":"The common cytokine receptor gamma chain family of cytokines","volume":"10","author":"Lin","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"aal1253","DOI":"10.1126\/scisignal.aal1253","article-title":"A hierarchy of affinities between cytokine receptors and the common gamma chain leads to pathway cross-talk","volume":"11","author":"Gonnord","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101421","DOI":"10.1016\/j.isci.2020.101421","article-title":"The cytokine receptor IL-7Ralpha impairs IL-2 receptor signaling and constrains the in vitro differentiation of Foxp3(+) Treg cells","volume":"23","author":"Waickman","year":"2020","journal-title":"iScience"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1073\/pnas.212214999","article-title":"IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes","volume":"99","author":"Xue","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1073\/pnas.93.8.3613","article-title":"Interleukin 2 (IL-2) and interleukin 7 (IL-7) reciprocally induce IL-7 and IL-2 receptors on gamma delta T-cell receptor-positive intraepithelial lymphocytes","volume":"93","author":"Fujihashi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18505","DOI":"10.1073\/pnas.1010249107","article-title":"Coordination of IL-7 receptor and T-cell receptor signaling by cell-division cycle 42 in T-cell homeostasis","volume":"107","author":"Guo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Chen, D., Tang, T.X., Deng, H., Yang, X.P., and Tang, Z.H. (2021). Interleukin-7 biology and its effects on immune cells: Mediator of generation, differentiation, survival, and homeostasis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.747324"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.20081922","article-title":"CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7Ralpha gene expression in early human thymopoiesis and leukemia","volume":"206","author":"Ballestar","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1074\/jbc.M700377200","article-title":"Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells","volume":"282","author":"DeKoter","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/ni1117","article-title":"GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells","volume":"5","author":"Xue","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"34386","DOI":"10.1074\/jbc.M112.378687","article-title":"CD8 lineage-specific regulation of interleukin-7 receptor expression by the transcriptional repressor Gfi1","volume":"287","author":"Ligons","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.4049\/jimmunol.2101046","article-title":"IL-7 receptor drives early T lineage progenitor expansion","volume":"209","author":"Paiva","year":"2022","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.184.1.289","article-title":"Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells","volume":"184","author":"He","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.1202573","article-title":"IL-7 produced by thymic epithelial cells plays a major role in the development of thymocytes and TCRgammadelta+ intraepithelial lymphocytes","volume":"190","author":"Shitara","year":"2013","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20040495","article-title":"The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling","volume":"200","author":"Hagenbeek","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20042393","article-title":"Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors","volume":"201","author":"Dias","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.smim.2012.02.001","article-title":"The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation","volume":"24","author":"Corfe","year":"2012","journal-title":"Semin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.20050158","article-title":"IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF","volume":"201","author":"Kikuchi","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1182\/blood-2010-08-302513","article-title":"IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells","volume":"118","author":"Nodland","year":"2011","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.smim.2012.03.002","article-title":"Multifaceted roles of interleukin-7 signaling for the development and function of innate lymphoid cells","volume":"24","author":"Vonarbourg","year":"2012","journal-title":"Semin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.20170518","article-title":"IL-7-dependent maintenance of ILC3s is required for normal entry of lymphocytes into lymph nodes","volume":"215","author":"Yang","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/JLB.3AB1220-819RRR","article-title":"IL-7 induces type 2 cytokine response in lung ILC2s and regulates GATA3 and CD25 expression","volume":"112","author":"Sheikh","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-065X.2006.00461.x","article-title":"Bone marrow versus thymic pathways of natural killer cell development","volume":"214","author":"Vosshenrich","year":"2006","journal-title":"Immunol. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CJI.0b013e3181cd872d","article-title":"IL-7 enhances survival of human CD56bright NK cells","volume":"33","author":"Michaud","year":"2010","journal-title":"J. Immunother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mi.2013.122","article-title":"IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival","volume":"7","author":"Webster","year":"2014","journal-title":"Mucosal Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"dev176180","DOI":"10.1242\/dev.176180","article-title":"The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident macrophage development","volume":"146","author":"Leung","year":"2019","journal-title":"Development"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.4049\/jimmunol.1000665","article-title":"Kit ligand and Il7 differentially regulate Peyer\u2019s patch and lymph node development","volume":"185","author":"Chappaz","year":"2010","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4049\/jimmunol.1500686","article-title":"Bimodal expansion of the lymphatic vessels is regulated by the sequential expression of IL-7 and lymphotoxin alpha1beta2 in newly formed tertiary lymphoid structures","volume":"197","author":"Nayar","year":"2016","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1182\/blood-2004-06-2484","article-title":"Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis","volume":"104","author":"Munitic","year":"2004","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jpeds.2005.10.004","article-title":"Omenn syndrome in an infant with IL7RA gene mutation","volume":"148","author":"Giliani","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mansour, R., Bsat, Y.E., Fadel, A., El-Orfali, Y., Noun, D., Tarek, N., Kabbara, N., Abboud, M., and Massaad, M.J. (2022). Diagnosis and treatment of a patient with severe combined immunodeficiency due to a novel homozygous mutation in the IL-7Ralpha chain. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.867837"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/humu.1188","article-title":"Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency","volume":"18","author":"Notarangelo","year":"2001","journal-title":"Hum. Mutat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00792599","article-title":"Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway","volume":"19","author":"Candotti","year":"1998","journal-title":"Springer Semin. Immunopathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2015.33","article-title":"Autoimmune diseases\u2014Connecting risk alleles with molecular traits of the immune system","volume":"17","author":"Rich","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.humimm.2014.04.006","article-title":"Autoimmune manifestations in SCID due to IL7R mutations: Omenn syndrome and cytopenias","volume":"75","author":"Zago","year":"2014","journal-title":"Hum. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/s41467-018-04521-0","article-title":"Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation","volume":"9","author":"Klammt","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10875-020-00884-6","article-title":"Developmental adaptive immune defects associated with STAT5B deficiency in three young siblings","volume":"41","author":"Foley","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.4049\/jimmunol.177.5.2770","article-title":"Decreased accumulation and regulatory function of CD4+ CD25high T cells in human STAT5b deficiency","volume":"177","author":"Cohen","year":"2006","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kanai, T., Jenks, J., and Nadeau, K.C. (2012). The STAT5b pathway defect and autoimmunity. Front. Immunol., 3.","DOI":"10.3389\/fimmu.2012.00234"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaci.2019.09.016","article-title":"Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function","volume":"145","author":"Klein","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Takeichi, T., Lee, J.Y.W., Okuno, Y., Miyasaka, Y., Murase, Y., Yoshikawa, T., Tanahashi, K., Nishida, E., Okamoto, T., and Ito, K. (2021). Autoinflammatory keratinization disease with hepatitis and autism reveals roles for JAK1 kinase hyperactivity in autoinflammation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.737747"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng2103","article-title":"Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis","volume":"39","author":"Gregory","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10753-013-9777-x","article-title":"Interleukin-7 receptor single nucleotide polymorphism rs6897932 (C\/T) and the susceptibility to systemic lupus erythematosus","volume":"37","author":"Wang","year":"2014","journal-title":"Inflammation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00439-010-0789-4","article-title":"Genetic variation in the IL7RA\/IL7 pathway increases multiple sclerosis susceptibility","volume":"127","author":"Zuvich","year":"2010","journal-title":"Hum. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e22675","DOI":"10.1002\/jcla.22675","article-title":"Interleukin-7 gene polymorphism rs766736182 associates with the risk of asthma in children","volume":"33","author":"Cao","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Zeng, Z., Mao, H., Lei, Q., and He, Y. (2025). IL-7 in autoimmune diseases: Mechanisms and therapeutic potential. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1545760"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0712135105","article-title":"CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity","volume":"105","author":"Calzascia","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/art.24754","article-title":"Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis","volume":"60","author":"Hartgring","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/annrheumdis-2012-202364","article-title":"Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus","volume":"72","author":"Badot","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"100788","DOI":"10.1016\/j.jbior.2021.100788","article-title":"Mutations that collaborate with IL-7Ra signaling pathways to drive ALL","volume":"80","author":"Rodrigues","year":"2021","journal-title":"Adv. Biol. Regul."},{"key":"ref_82","first-page":"158","article-title":"IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition","volume":"142","author":"Courtois","year":"2023","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.2019000982","article-title":"IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia","volume":"134","author":"Mosquera","year":"2019","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1038\/ncomms6794","article-title":"ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling","volume":"6","author":"Goossens","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/leu.2017.225","article-title":"The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling","volume":"32","author":"Girardi","year":"2018","journal-title":"Leukemia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/leu.2016.100","article-title":"Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling","volume":"30","author":"Tremblay","year":"2016","journal-title":"Leukemia"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Campos, L.W., Pissinato, L.G., and Yunes, J.A. (2019). Deleterious and oncogenic mutations in the IL7RA. Cancers, 11.","DOI":"10.3390\/cancers11121952"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ng.924","article-title":"Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia","volume":"43","author":"Zenatti","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias","volume":"208","author":"Shochat","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20072182","article-title":"Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia","volume":"205","author":"Flex","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000531522","article-title":"Characteristics of molecular genetic mutations and their correlation with prognosis in adolescent and adult patients with acute lymphoblastic leukemia","volume":"102","author":"Sun","year":"2024","journal-title":"Oncology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/leu.2016.83","article-title":"MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia","volume":"30","author":"Uitdehaag","year":"2016","journal-title":"Leukemia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41375-018-0127-8","article-title":"Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia","volume":"32","author":"Demeyer","year":"2018","journal-title":"Leukemia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1097\/HS9.0000000000000637","article-title":"Oncogenic cooperation between IL7R-JAK-STAT pathway mutations","volume":"5","author":"Lodewijckx","year":"2021","journal-title":"Hemasphere"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Downes, C.E., McClure, B.J., McDougal, D.P., Heatley, S.L., Bruning, J.B., Thomas, D., Yeung, D.T., and White, D.L. (2022). JAK2 alterations in acute lymphoblastic leukemia: Molecular insights for superior precision medicine strategies. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.942053"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1182\/bloodadvances.2019000163","article-title":"Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"4","author":"Harvey","year":"2020","journal-title":"Blood Adv."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature25795","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","author":"Ma","year":"2018","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41375-017-0001-0","article-title":"Mutant IL-7Ralpha and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia","volume":"32","author":"Cramer","year":"2018","journal-title":"Leukemia"},{"key":"ref_102","first-page":"1726","article-title":"Mechanism of co-operation of mutant IL-7Ralpha and mutant NRAS in acute lymphoblastic leukemia: Role of MYC","volume":"109","author":"Winer","year":"2024","journal-title":"Haematologica"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/s41375-022-01590-5","article-title":"Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia","volume":"36","author":"Oliveira","year":"2022","journal-title":"Leukemia"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/s41375-019-0685-4","article-title":"Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation","volume":"34","author":"Kim","year":"2020","journal-title":"Leukemia"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2159-8290.CD-17-0583","article-title":"HOXA9 cooperates with activated JAK\/STAT signaling to drive leukemia development","volume":"8","author":"Demeyer","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1182\/blood-2012-08-451278","article-title":"In vivo leukemogenic potential of an interleukin 7 receptor alpha chain mutant in hematopoietic stem and progenitor cells","volume":"122","author":"Yokoyama","year":"2013","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3324\/haematol.2011.043083","article-title":"Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia","volume":"96","author":"Wang","year":"2011","journal-title":"Haematologica"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41467-022-28218-7","article-title":"An instructive role for Interleukin-7 receptor alpha in the development of human B-cell precursor leukemia","volume":"13","author":"Geron","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41375-021-01326-x","article-title":"Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice","volume":"36","author":"Thomas","year":"2022","journal-title":"Leukemia"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.4110\/in.2024.24.e9","article-title":"Harnessing the power of IL-7 to boost T cell immunity in experimental and clinical immunotherapies","volume":"24","author":"Park","year":"2024","journal-title":"Immune Netw."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e002903","DOI":"10.1136\/jitc-2021-002903","article-title":"IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)","volume":"9","author":"Pachynski","year":"2021","journal-title":"J. Immunother. Cancer."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy","volume":"16","author":"Sportes","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Yu, E.M., Cho, E., Singh, R., Kim, S.H., Han, C., Han, S., Lee, D.G., Kim, Y.H., Kwon, B.S., and Choi, B.K. (2021). IL7-Fc enhances the efficacy of adoptive T cell therapy under lymphopenic conditions in a murine melanoma model. Cells, 10.","DOI":"10.3390\/cells10082018"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1078-0432.CCR-21-0947","article-title":"Long-acting recombinant human interleukin-7, NT-I7, increases cytotoxic CD8 T cells and enhances survival in mouse glioma models","volume":"28","author":"Campian","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"vdaf117","DOI":"10.1093\/noajnl\/vdaf117","article-title":"Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma","volume":"7","author":"Campian","year":"2025","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Li, G., Zhang, Q., Han, Z., Zhu, Y., Shen, H., Liu, Z., Zhou, Z., Ding, W., Han, S., and He, J. (2021). IL-7 and CCR2b co-expression-mediated enhanced CAR-T survival and Infiltration in solid tumors. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.734593"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"896","DOI":"10.20892\/j.issn.2095-3941.2020.0069","article-title":"Current management of chemotherapy-induced neutropenia in adults: Key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association","volume":"17","author":"Ba","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s00262-021-02853-3","article-title":"Enhanced anti-tumor efficacy of IL-7\/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models","volume":"70","author":"Goto","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1535-7163.MCT-21-0400","article-title":"Enhanced antitumor responses of tumor antigen-specific TCR T cells genetically engineered to produce IL7 and CCL19","volume":"21","author":"Tokunaga","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2112898","DOI":"10.1155\/2022\/2112898","article-title":"Folate receptor-alpha targeted 7x19 CAR-gammadeltaT suppressed triple-negative breast cancer xenograft model in mice","volume":"2022","author":"Ye","year":"2022","journal-title":"J. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13045-021-01128-9","article-title":"IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin","volume":"14","author":"Pang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1038\/s41598-019-43294-4","article-title":"Interleukin-7 contributes to the invasiveness of Prostate cancer cells by promoting epithelial-mesenchymal transition","volume":"9","author":"Seol","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4795171","DOI":"10.1155\/2020\/4795171","article-title":"Engineered IL-7 receptor enhances the therapeutic effect of AXL-CAR-T cells on triple-negative breast cancer","volume":"2020","author":"Zhao","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Noh, K.E., Lee, J.H., Choi, S.Y., Jung, N.C., Nam, J.H., Oh, J.S., Song, J.Y., Seo, H.G., Wang, Y., and Lee, H.S. (2021). TGF-beta\/IL-7 chimeric switch receptor-expressing CAR-T cells inhibit recurrence of CD19-positive B cell lymphoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168706"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/hum.2024.103","article-title":"Alpharetroviral vector-mediated gene therapy for IL7RA-deficient severe combined immunodeficiency","volume":"35","author":"Ha","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/hum.2015.137","article-title":"Gene therapy for X-linked severe combined immunodeficiency: Where do we stand?","volume":"27","author":"Cavazzana","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/hum.2023.100","article-title":"CRISPR\/Cas9-based disease modeling and functional correction of interleukin 7 receptor alpha severe combined immunodeficiency in T-lymphocytes and hematopoietic stem cells","volume":"35","author":"Rai","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood.2024027267","article-title":"How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission","volume":"146","author":"Aldoss","year":"2025","journal-title":"Blood"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41375-019-0531-8","article-title":"New anti-IL-7Ralpha monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models","volume":"34","author":"Hixon","year":"2020","journal-title":"Leukemia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"10735","DOI":"10.1038\/s41598-017-11255-4","article-title":"Immunoregulation by IL-7R-targeting antibody-drug conjugates: Overcoming steroid-resistance in cancer and autoimmune disease","volume":"7","author":"Yasunaga","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/art.27578","article-title":"Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators","volume":"62","author":"Hartgring","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-019-0401-3","article-title":"Model-based characterization of the pharmacokinetics, target engagement biomarkers, and immunomodulatory activity of PF-06342674, a humanized mAb against IL-7 receptor-alpha, in adults with Type 1 diabetes","volume":"22","author":"Williams","year":"2020","journal-title":"AAPS J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"126054","DOI":"10.1172\/jci.insight.126054","article-title":"Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes","volume":"4","author":"Herold","year":"2019","journal-title":"JCI Insight"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Raivola, J., Haikarainen, T., Abraham, B.G., and Silvennoinen, O. (2021). Janus kinases in leukemia. Cancers, 13.","DOI":"10.3390\/cancers13040800"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Shawky, A.M., Almalki, F.A., Abdalla, A.N., Abdelazeem, A.H., and Gouda, A.M. (2022). A comprehensive overview of globally approved JAK inhibitors. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051001"},{"key":"ref_137","first-page":"872","article-title":"Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: A case report and literature review","volume":"45","author":"Xu","year":"2024","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa1507247","article-title":"Baricitinib in patients with refractory rheumatoid arthritis","volume":"374","author":"Genovese","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e20232387","DOI":"10.1084\/jem.20232387","article-title":"Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis","volume":"221","author":"Horesh","year":"2024","journal-title":"J. Exp. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e150849","DOI":"10.1172\/jci.insight.150849","article-title":"Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation","volume":"7","author":"Biggs","year":"2022","journal-title":"JCI Insight"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Raivola, J., Hammaren, H.M., Virtanen, A.T., Bulleeraz, V., Ward, A.C., and Silvennoinen, O. (2018). Hyperactivation of oncogenic JAK3 mutants depend on ATP binding to the pseudokinase domain. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00560"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00018-022-04361-8","article-title":"In vivo impact of JAK3 A573V mutation revealed using zebrafish","volume":"79","author":"Basheer","year":"2022","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:24:15Z","timestamp":1770035055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":144,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["biom16020219"],"URL":"https:\/\/doi.org\/10.3390\/biom16020219","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}